Pharma Sector to Consolidate, Focus on R&D

The Chinese pharmaceutical market is expected to become the fifth-largest pharmaceutical market by 2010, compared with ninth currently, analysts say. The industry is also going through a transitional phase, with increased consolidation and more companies getting involved in R&D, analysts add. China’s pharma market was worth $22 billion in 2007, Frost & Sullivan (Kolkata, India) says. The market is highly fragmented with more than 30,000 manufacturers, of which more than 90% are small and medium-size enterprises, Frost & Sullivan says. As a...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers